Remdesivir drug to be approved for coronavirus patients in May

Japan Times

28 April 2020 - The government will soon approve the anti-viral drug remdesivir for treatment of coronavirus patients, Japan’s first such decision amid the pandemic, according to Prime Minister Shinzo Abe.

A government official said separately that the drug will be approved as early as next month to treat patients with COVID-19, the respiratory illness caused by the novel coronavirus, as moves to develop therapeutic drugs and vaccines have been accelerating around the globe.

“The pharmaceutical approval (of remdesivir) will be possible shortly,” Abe told a Diet session Monday.

Read Japan Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Japan